Company Filing History:
Years Active: 2006
Title: Dimitri Georgiadis: Innovator in Medicinal Chemistry
Introduction
Dimitri Georgiadis is a notable inventor based in Athens, Greece. He has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative compounds for therapeutic applications. His work focuses on the selective inhibition of enzymes that play critical roles in various physiological processes.
Latest Patents
Dimitri holds 1 patent for his invention titled "Phosphinic pseudopeptide derivatives for the selective inhibition of the C-terminal active site of angiotensin I converting enzyme (ACE)." This invention relates to the use of phosphinic pseudopeptide derivatives for the production of a medicament aimed at selectively inhibiting the active C-terminal site of ACE. The derivatives are characterized by a specific formula, where R may represent a protecting group for amino functions commonly used in peptide chemistry or an amino acid or peptide protected by such groups. Additionally, R and R correspond to a natural or unnatural amino acid side chain, while R represents a hydrogen atom or a counterion.
Career Highlights
Dimitri is currently affiliated with the Commissariat à l'Énergie Atomique, where he continues to advance his research in the field of medicinal chemistry. His work has garnered attention for its potential applications in treating various health conditions through targeted enzyme inhibition.
Collaborations
Dimitri collaborates with Vincent Dive, a fellow researcher in the field. Their partnership enhances the scope of their research and contributes to the development of innovative therapeutic solutions.
Conclusion
Dimitri Georgiadis is a prominent figure in the realm of medicinal chemistry, with a focus on enzyme inhibition. His innovative work and patent contributions reflect his commitment to advancing healthcare solutions.